Published in J Am Soc Nephrol on October 09, 2009
Systemic PPARγ deletion causes severe disturbance in fluid homeostasis in mice. Physiol Genomics (2015) 1.40
The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies. Cell Mol Life Sci (2012) 0.99
Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats. PPAR Res (2010) 0.90
Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors. PPAR Res (2010) 0.80
Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease. PPAR Res (2012) 0.77
Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells. PPAR Res (2013) 0.77
Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice. Am J Pathol (2013) 0.76
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective. Nat Rev Drug Discov (2013) 1.78
Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin Appl (2008) 1.22
Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA. Proc Natl Acad Sci U S A (2008) 1.15
Functional characterization of wild-type and mutated pendrin (SLC26A4), the anion transporter involved in Pendred syndrome. J Mol Endocrinol (2009) 1.14
Calcium oxalate stone formation in the inner ear as a result of an Slc26a4 mutation. J Biol Chem (2010) 1.08
PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel. Pflugers Arch (2005) 1.00
Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease. Exp Biol Med (Maywood) (2008) 0.97
sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport. Am J Physiol Cell Physiol (2002) 0.95
Hormonal regulation of the epithelial Na+ channel: from amphibians to mammals. Gen Comp Endocrinol (2006) 0.94
PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line. Am J Physiol Renal Physiol (2009) 0.94
Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone. Pflugers Arch (2008) 0.91
Cyclic adenosine monophosphate regulation of ion transport in porcine vocal fold mucosae. Laryngoscope (2008) 0.89
Phosphoinositide lipid second messengers: new paradigms for transepithelial signal transduction. Pflugers Arch (2004) 0.88
Functional effects of nanoparticle exposure on Calu-3 airway epithelial cells. Cell Physiol Biochem (2012) 0.86
The role of the phosphoinositide pathway in hormonal regulation of the epithelial sodium channel. Adv Exp Med Biol (2004) 0.85
Molecular and functional characterization of human pendrin and its allelic variants. Cell Physiol Biochem (2011) 0.84
Impact of bicarbonate, ammonium chloride, and acetazolamide on hepatic and renal SLC26A4 expression. Cell Physiol Biochem (2011) 0.84
Identification of allelic variants of pendrin (SLC26A4) with loss and gain of function. Cell Physiol Biochem (2011) 0.84
Vasopressin regulates the phosphorylation state of AMP-activated protein kinase (AMPK) in MDCK-C7 cells. Cell Physiol Biochem (2008) 0.84
Curcumin affects cell survival and cell volume regulation in human renal and intestinal cells. Toxicology (2011) 0.83
Expression of the unconventional myosin Myo1c alters sodium transport in M1 collecting duct cells. Am J Physiol Cell Physiol (2005) 0.83
The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid. Proteomics Clin Appl (2009) 0.82
60kDa lysophospholipase, a new Sgk1 molecular partner involved in the regulation of ENaC. Cell Physiol Biochem (2010) 0.82
The molecular and functional interaction between ICln and HSPC038 proteins modulates the regulation of cell volume. J Biol Chem (2011) 0.81
Use of the operon structure of the C. elegans genome as a tool to identify functionally related proteins. Cell Physiol Biochem (2013) 0.80
A human polymorphism affects NEDD4L subcellular targeting by leading to two isoforms that contain or lack a C2 domain. BMC Cell Biol (2009) 0.80
Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease. Proteomics (2009) 0.80
Protein expression profiles of intestinal epithelial co-cultures: effect of functionalised carbon nanotube exposure. Int J Biomed Nanosci Nanotechnol (2013) 0.80
EGF stimulates IClswell by a redistribution of proteins involved in cell volume regulation. Cell Physiol Biochem (2011) 0.79
The ESF meeting on "The proteomics, epigenetics and pharmacogenetics of pendrin". Cell Physiol Biochem (2011) 0.77
Methylation of the human pendrin promoter. Cell Physiol Biochem (2011) 0.77
Functional characterization of pendrin mutations found in the Israeli and Palestinian populations. Cell Physiol Biochem (2011) 0.77
A FRET-based approach for quantitative evaluation of forskolin-induced pendrin trafficking at the plasma membrane in bronchial NCI H292 cells. Cell Physiol Biochem (2013) 0.77
Co-regulated pendrin and aquaporin 5 expression and trafficking in Type-B intercalated cells under potassium depletion. Cell Physiol Biochem (2013) 0.76
The human pendrin promoter contains two N(4) GAS motifs with different functional relevance. Cell Physiol Biochem (2013) 0.75
Interleukin-4 Induces CpG Site-Specific Demethylation of the Pendrin Promoter in Primary Human Bronchial Epithelial Cells. Cell Physiol Biochem (2017) 0.75
Synopsis of the 48 annual meeting of the Lake Cumberland Biological Transport Group and the second biannual meeting of the Pendrin Consortium. Cell Physiol Biochem (2013) 0.75
Effect of Known Inhibitors of Ion Transport on Pendrin (SLC26A4) Activity in a Human Kidney Cell Line. Cell Physiol Biochem (2016) 0.75